Net profit of Windlas Biotech rose 46.49% to Rs 9.80 crore in the quarter ended June 2022 as against Rs 6.69 crore during the previous quarter ended June 2021. Sales rose 8.09% to Rs 119.94 crore in the quarter ended June 2022 as against Rs 110.96 crore during the previous quarter ended June 2021.
| Particulars | Quarter Ended | ||
| ? | Jun. 2022 | Jun. 2021 | % Var. |
| Sales | 119.94 | 110.96 | 8 |
| OPM % | 11.50 | 11.16 | – |
| PBDT | 16.30 | 12.59 | 29 |
| PBT | 13.54 | 9.57 | 41 |
| NP | 9.80 | 6.69 | 46 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
